Director of Australian Synchrotron announced
The Synchrotron Light Source Australia (SLSA) Board today announced the appointment of Professor Andrew Peele as Director of the Australian Synchrotron. Professor Peele has held the role on an interim basis since the beginning of 2013, overseeing the day-to-day delivery of world-class science at the facility.
The synchrotron, located in Clayton, Melbourne, is one of Australia’s premier user facilities for science and delivers important outcomes across a broad number of research disciplines. It has been under the management of the Australian Nuclear Science and Technology Organisation (ANSTO) since 1 January 2013, when the two organisations formed an official partnership.
ANSTO’s Chief Executive Officer, Dr Adi Paterson, noted that the recruitment process for the position was conducted internationally, “and it is a credit to Professor Peele that he was confirmed the best candidate from a very distinguished field of applicants”.
“Professor Peele has been acting as Interim Director for some time now, and I have great confidence he will continue to steer the synchrotron in the right direction,” Dr Paterson said.
Following the announcement of his appointment, Professor Peele stated that finalising a strategy for the Australian Synchrotron, with input from its extensive user community and stakeholders who have contributed to its development, was a key component to ensuring the future of the synchrotron.
“I am confident that the dedicated staff at the synchrotron will continue to build on the magnificent research outcomes and achievements to date, enabling a bright future for science, industry and the economy,” he said.
Evident names 5th Annual Image of the Year Award winners
View the six winning entries in Evident's 5th Annual Image of the Year Award — a...
Fellowships and scholarships support women in science
The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing...
2024 GSK Award recognises neurodegeneration researcher
Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in...